中國玻璃(03300.HK)盈警:預期2024年虧損不超9.8億元
格隆匯3月14日丨中國玻璃(03300.HK)公吿,集團預期截至2024年12月31日止年度將錄得人民幣不超過9.8億元的虧損,而截至2023年12月30日止年度集團錄得虧損淨額約人民幣4.87億元。
該虧損主要受以下綜合因素影響:(1)中國地產行業不景氣週期延續,光伏新能源行業短期供需矛盾突出,導致建築玻璃及光伏玻璃市場價格整體維持低位;(2)地緣政治局勢動盪,貿易保護主義升級,貨幣匯率波動風險加劇,使得海外生產基地年內強勁的業績表現對集團淨利潤貢獻度降低;及(3)經綜合評估生產線狀態,對部分生產線計提了相應減值撥備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.